Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

Clinical trial NCT06052839 · RECRUITING

Trial details

NCT number: NCT06052839
Sponsor: Dan Zandberg
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Start date: 2023-10-03
Primary completion: 2026-12-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.